1. Home
  2. CRL vs CWAN Comparison

CRL vs CWAN Comparison

Compare CRL & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$214.20

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Logo Clearwater Analytics Holdings Inc.

CWAN

Clearwater Analytics Holdings Inc.

HOLD

Current Price

$24.56

Market Cap

7.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRL
CWAN
Founded
1947
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
7.2B
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
CRL
CWAN
Price
$214.20
$24.56
Analyst Decision
Buy
Hold
Analyst Count
12
11
Target Price
$198.27
$25.09
AVG Volume (30 Days)
752.4K
6.6M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,857,601,000.00
$731,368,000.00
Revenue This Year
N/A
$31.67
Revenue Next Year
$3.04
$18.27
P/E Ratio
N/A
N/A
Revenue Growth
10.48
61.88
52 Week Low
$144.26
$15.74
52 Week High
$228.88
$24.56

Technical Indicators

Market Signals
Indicator
CRL
CWAN
Relative Strength Index (RSI) 73.04 67.84
Support Level $193.41 $24.04
Resistance Level $228.64 N/A
Average True Range (ATR) 7.45 0.06
MACD 2.68 0.01
Stochastic Oscillator 92.13 100.00

Price Performance

Historical Comparison
CRL
CWAN

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About CWAN Clearwater Analytics Holdings Inc.

Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.

Share on Social Networks: